A BuiltForAI Property
507 drug classes · 1,794 molecules · updated daily

Drug classes by Part D spend.

Every therapeutic class represented in our 3,186-drug Part D-relevant universe, ranked by CY2024 Part D spend. Click any class to see member drugs, their cost spread, generic competition, and class-level Q&A.

Last updated
Class membership: drug master, refreshed weeklyPart D Spend: annual (CY24)NADAC: weekly

Every class, ranked by plan spend.

507 classesTotal $307.07B CY24
01
Factor Xa Inhibitor
4 molecules in class · 23 total generic manufacturers across the class
CY24 Part D spend$41.74B
Molecules4
Class share 13.6% of tracked Part D spend
Explorer
View class
Open →
02
GLP-1 Receptor Agonist
4 molecules in class · 6 total generic manufacturers across the class
CY24 Part D spend$32.44B
Molecules4
Class share 10.6% of tracked Part D spend
Explorer
View class
Open →
03
Kinase Inhibitor
48 molecules in class · 68 total generic manufacturers across the class
CY24 Part D spend$26.93B
Molecules48
Class share 8.8% of tracked Part D spend
Explorer
View class
Open →
05
Thalidomide Analog
2 molecules in class · 23 total generic manufacturers across the class
CY24 Part D spend$13.44B
Molecules2
Class share 4.4% of tracked Part D spend
Explorer
View class
Open →
07
TNF Blocker
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$8.57B
Molecules1
Class share 2.8% of tracked Part D spend
Explorer
View class
Open →
08
Atypical Antipsychotic
18 molecules in class · 137 total generic manufacturers across the class
CY24 Part D spend$6.60B
Molecules18
Class share 2.1% of tracked Part D spend
Explorer
View class
Open →
09
Dipeptidyl Peptidase 4 Inhibitor
5 molecules in class · 15 total generic manufacturers across the class
CY24 Part D spend$6.52B
Molecules5
Class share 2.1% of tracked Part D spend
Explorer
View class
Open →
10
Tumor Necrosis Factor Blocker
10 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$6.32B
Molecules10
Class share 2.1% of tracked Part D spend
Explorer
View class
Open →
11
Androgen Receptor Inhibitor
5 molecules in class · 8 total generic manufacturers across the class
CY24 Part D spend$5.85B
Molecules5
Class share 1.9% of tracked Part D spend
Explorer
View class
Open →
12
Interleukin-23 Antagonist
4 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$5.78B
Molecules4
Class share 1.9% of tracked Part D spend
Explorer
View class
Open →
13
Insulin Analog
16 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$5.21B
Molecules16
Class share 1.7% of tracked Part D spend
Explorer
View class
Open →
14
Interleukin-12 Antagonist
6 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$5.16B
Molecules6
Class share 1.7% of tracked Part D spend
Explorer
View class
Open →
15
beta3-Adrenergic Agonist
2 molecules in class · 6 total generic manufacturers across the class
CY24 Part D spend$5.05B
Molecules2
Class share 1.6% of tracked Part D spend
Explorer
View class
Open →
17
PCSK9 Inhibitor
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$3.75B
Molecules2
Class share 1.2% of tracked Part D spend
Explorer
View class
Open →
18
Interleukin-17A Antagonist
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$3.63B
Molecules2
Class share 1.2% of tracked Part D spend
Explorer
View class
Open →
19
Guanylate Cyclase-C Agonist
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$3.26B
Molecules2
Class share 1.1% of tracked Part D spend
Explorer
View class
Open →
21
Janus Kinase Inhibitor
4 molecules in class · 1 total generic manufacturers across the class
CY24 Part D spend$2.49B
Molecules4
Class share 0.8% of tracked Part D spend
Explorer
View class
Open →
22
HMG-CoA Reductase Inhibitor
6 molecules in class · 70 total generic manufacturers across the class
CY24 Part D spend$2.33B
Molecules6
Class share 0.8% of tracked Part D spend
Explorer
View class
Open →
23
Endothelin Receptor Antagonist
6 molecules in class · 17 total generic manufacturers across the class
CY24 Part D spend$2.33B
Molecules6
Class share 0.8% of tracked Part D spend
Explorer
View class
Open →
25
Rifamycin Antibacterial
2 molecules in class · 7 total generic manufacturers across the class
CY24 Part D spend$1.81B
Molecules2
Class share 0.6% of tracked Part D spend
Explorer
View class
Open →
26
Phosphodiesterase 4 Inhibitor
3 molecules in class · 14 total generic manufacturers across the class
CY24 Part D spend$1.79B
Molecules3
Class share 0.6% of tracked Part D spend
Explorer
View class
Open →
27
BCL-2 Inhibitor
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$1.51B
Molecules1
Class share 0.5% of tracked Part D spend
Explorer
View class
Open →
28
Proton Pump Inhibitor
10 molecules in class · 79 total generic manufacturers across the class
CY24 Part D spend$1.50B
Molecules10
Class share 0.5% of tracked Part D spend
Explorer
View class
Open →
29
CD20-directed Cytolytic Antibody
8 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$1.46B
Molecules8
Class share 0.5% of tracked Part D spend
Explorer
View class
Open →
30
Prostacyclin Receptor Agonist
1 molecule in class · 1 total generic manufacturers across the class
CY24 Part D spend$1.41B
Molecules1
Class share 0.5% of tracked Part D spend
Explorer
View class
Open →
31
Prostaglandin Analog
15 molecules in class · 40 total generic manufacturers across the class
CY24 Part D spend$1.29B
Molecules15
Class share 0.4% of tracked Part D spend
Explorer
View class
Open →
32
P2Y12 Platelet Inhibitor
5 molecules in class · 39 total generic manufacturers across the class
CY24 Part D spend$1.29B
Molecules5
Class share 0.4% of tracked Part D spend
Explorer
View class
Open →
33
Nonsteroidal Anti-inflammatory Drug
35 molecules in class · 184 total generic manufacturers across the class
CY24 Part D spend$1.27B
Molecules35
Class share 0.4% of tracked Part D spend
Explorer
View class
Open →
34
RANK Ligand Inhibitor
5 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$1.26B
Molecules5
Class share 0.4% of tracked Part D spend
Explorer
View class
Open →
36
Corticosteroid
68 molecules in class · 249 total generic manufacturers across the class
CY24 Part D spend$1.26B
Molecules68
Class share 0.4% of tracked Part D spend
Explorer
View class
Open →
37
Prostacycline Vasodilator
4 molecules in class · 8 total generic manufacturers across the class
CY24 Part D spend$1.24B
Molecules4
Class share 0.4% of tracked Part D spend
Explorer
View class
Open →
40
Soluble Guanylate Cyclase Stimulator
2 molecules in class · 1 total generic manufacturers across the class
CY24 Part D spend$1.16B
Molecules2
Class share 0.4% of tracked Part D spend
Explorer
View class
Open →
42
Opioid Agonist
16 molecules in class · 112 total generic manufacturers across the class
CY24 Part D spend$1.11B
Molecules16
Class share 0.4% of tracked Part D spend
Explorer
View class
Open →
43
Beta-Adrenergic Blocker
3 molecules in class · 57 total generic manufacturers across the class
CY24 Part D spend$1.06B
Molecules3
Class share 0.3% of tracked Part D spend
Explorer
View class
Open →
45
Cytochrome P450 17A1 Inhibitor
1 molecule in class · 12 total generic manufacturers across the class
CY24 Part D spend$1.02B
Molecules1
Class share 0.3% of tracked Part D spend
Explorer
View class
Open →
46
Antiarrhythmic
9 molecules in class · 86 total generic manufacturers across the class
CY24 Part D spend$1.00B
Molecules9
Class share 0.3% of tracked Part D spend
Explorer
View class
Open →
48
Estrogen
21 molecules in class · 54 total generic manufacturers across the class
CY24 Part D spend$973.4M
Molecules21
Class share 0.3% of tracked Part D spend
Explorer
View class
Open →
50
Interleukin-6 Receptor Antagonist
3 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$911.4M
Molecules3
Class share 0.3% of tracked Part D spend
Explorer
View class
Open →
51
Anticonvulsant
3 molecules in class · 103 total generic manufacturers across the class
CY24 Part D spend$830.3M
Molecules3
Class share 0.3% of tracked Part D spend
Explorer
View class
Open →
53
Parathyroid Hormone Analog
1 molecule in class · 3 total generic manufacturers across the class
CY24 Part D spend$757.1M
Molecules1
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
55
Anti-epileptic Agent
14 molecules in class · 104 total generic manufacturers across the class
CY24 Part D spend$714.8M
Molecules14
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
58
Phosphate Binder
3 molecules in class · 21 total generic manufacturers across the class
CY24 Part D spend$645.2M
Molecules3
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
59
Benzodiazepine
22 molecules in class · 94 total generic manufacturers across the class
CY24 Part D spend$638.0M
Molecules22
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
60
Biguanide (Antidiabetic)
1 molecule in class · 40 total generic manufacturers across the class
CY24 Part D spend$617.0M
Molecules1
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
61
alpha-Adrenergic Agonist
16 molecules in class · 45 total generic manufacturers across the class
CY24 Part D spend$603.4M
Molecules16
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
62
Angiotensin 2 Receptor Blocker
11 molecules in class · 104 total generic manufacturers across the class
CY24 Part D spend$561.9M
Molecules11
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
63
Progestin Antagonist
1 molecule in class · 3 total generic manufacturers across the class
CY24 Part D spend$550.8M
Molecules1
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
64
Mood Stabilizer
3 molecules in class · 42 total generic manufacturers across the class
CY24 Part D spend$550.4M
Molecules3
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
65
GLP-2 Analog
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$549.0M
Molecules1
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
68
Partial Opioid Agonist
3 molecules in class · 15 total generic manufacturers across the class
CY24 Part D spend$536.9M
Molecules3
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
69
Cardiac Myosin Inhibitor
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$533.9M
Molecules1
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
70
Interferon beta
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$528.5M
Molecules2
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
71
Anti-IgE
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$522.7M
Molecules1
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
73
Aminosalicylate
3 molecules in class · 32 total generic manufacturers across the class
CY24 Part D spend$511.7M
Molecules3
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
74
Interleukin-5 Antagonist
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$511.2M
Molecules2
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
75
Serotonin Reuptake Inhibitor
4 molecules in class · 54 total generic manufacturers across the class
CY24 Part D spend$508.3M
Molecules4
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
76
Isocitrate Dehydrogenase 1 Inhibitor
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$503.9M
Molecules2
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
77
Azole Antifungal
20 molecules in class · 98 total generic manufacturers across the class
CY24 Part D spend$501.4M
Molecules20
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
78
ACE Inhibitor
5 molecules in class · 42 total generic manufacturers across the class
CY24 Part D spend$482.0M
Molecules5
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
80
alpha-Adrenergic Blocker
6 molecules in class · 49 total generic manufacturers across the class
CY24 Part D spend$479.2M
Molecules6
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
81
Potassium Supplement
1 molecule in class · 36 total generic manufacturers across the class
CY24 Part D spend$476.9M
Molecules1
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
82
Calcium Channel Blocker
2 molecules in class · 43 total generic manufacturers across the class
CY24 Part D spend$467.4M
Molecules2
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
83
Alpha-1 Adrenergic Blocker
1 molecule in class · 12 total generic manufacturers across the class
CY24 Part D spend$465.2M
Molecules1
Class share 0.2% of tracked Part D spend
Explorer
View class
Open →
84
Cholinergic Muscarinic Antagonist
5 molecules in class · 60 total generic manufacturers across the class
CY24 Part D spend$457.1M
Molecules5
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
85
Loop Diuretic
5 molecules in class · 53 total generic manufacturers across the class
CY24 Part D spend$448.1M
Molecules5
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
86
Estrogen Receptor Antagonist
3 molecules in class · 13 total generic manufacturers across the class
CY24 Part D spend$437.1M
Molecules3
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
88
Complement Inhibitor
7 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$405.0M
Molecules7
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
89
Plasma Kallikrein Inhibitor
3 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$384.0M
Molecules3
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
90
beta-Adrenergic Blocker
10 molecules in class · 87 total generic manufacturers across the class
CY24 Part D spend$376.5M
Molecules10
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
91
SGLT2 Inhibitor (Antidiabetic)
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$364.8M
Molecules2
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
92
Purine Antimetabolite
2 molecules in class · 10 total generic manufacturers across the class
CY24 Part D spend$364.2M
Molecules2
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
93
Cholinesterase Inhibitor
5 molecules in class · 59 total generic manufacturers across the class
CY24 Part D spend$361.4M
Molecules5
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
94
Hypoxia-inducible Factor Inhibitor
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$356.6M
Molecules1
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
95
Anticholinergic
12 molecules in class · 75 total generic manufacturers across the class
CY24 Part D spend$354.1M
Molecules12
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
96
Amide Local Anesthetic
23 molecules in class · 47 total generic manufacturers across the class
CY24 Part D spend$350.5M
Molecules23
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
99
Thymic Stromal Lymphopoietin Blocker
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$340.1M
Molecules1
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
101
Integrin Receptor Antagonist
3 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$338.9M
Molecules3
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
102
Leukocyte Growth Factor
15 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$336.5M
Molecules15
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
104
Uric Acid-specific Enzyme
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$322.8M
Molecules1
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
106
Pyrimidine Synthesis Inhibitor
1 molecule in class · 13 total generic manufacturers across the class
CY24 Part D spend$319.2M
Molecules1
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
108
Central Nervous System Stimulant
14 molecules in class · 90 total generic manufacturers across the class
CY24 Part D spend$296.7M
Molecules14
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
109
Orexin Receptor Antagonist
3 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$291.6M
Molecules3
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
112
Histamine-2 Receptor Antagonist
6 molecules in class · 52 total generic manufacturers across the class
CY24 Part D spend$266.7M
Molecules6
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
113
Recombinant Human Growth Hormone
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$261.4M
Molecules2
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
114
Pyridone
2 molecules in class · 14 total generic manufacturers across the class
CY24 Part D spend$259.4M
Molecules2
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
115
Serotonin Modulator (Antidepressant)
1 molecule in class · 12 total generic manufacturers across the class
CY24 Part D spend$255.2M
Molecules1
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
116
Tricyclic Antidepressant
7 molecules in class · 67 total generic manufacturers across the class
CY24 Part D spend$247.4M
Molecules7
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
117
Serotonin-3 Receptor Antagonist
6 molecules in class · 49 total generic manufacturers across the class
CY24 Part D spend$244.9M
Molecules6
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
118
Macrolide Antibacterial
1 molecule in class · 3 total generic manufacturers across the class
CY24 Part D spend$241.3M
Molecules1
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
121
Leukotriene Receptor Antagonist
2 molecules in class · 24 total generic manufacturers across the class
CY24 Part D spend$233.0M
Molecules2
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
123
Phosphodiesterase 5 Inhibitor
4 molecules in class · 59 total generic manufacturers across the class
CY24 Part D spend$228.0M
Molecules4
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
124
Vasopressin V2 Receptor Antagonist
1 molecule in class · 6 total generic manufacturers across the class
CY24 Part D spend$227.8M
Molecules1
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
125
Nonergot Dopamine Agonist
3 molecules in class · 29 total generic manufacturers across the class
CY24 Part D spend$226.1M
Molecules3
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
126
Skeletal Muscle Relaxant
3 molecules in class · 37 total generic manufacturers across the class
CY24 Part D spend$221.1M
Molecules3
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
127
Nucleoside Metabolic Inhibitor
16 molecules in class · 97 total generic manufacturers across the class
CY24 Part D spend$215.1M
Molecules16
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
128
Histamine-1 Receptor Antagonist
10 molecules in class · 53 total generic manufacturers across the class
CY24 Part D spend$214.1M
Molecules10
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
129
Androgen
7 molecules in class · 28 total generic manufacturers across the class
CY24 Part D spend$210.9M
Molecules7
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
130
Nitrate Vasodilator
8 molecules in class · 31 total generic manufacturers across the class
CY24 Part D spend$205.9M
Molecules8
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
131
Sulfonylurea
8 molecules in class · 36 total generic manufacturers across the class
CY24 Part D spend$204.6M
Molecules8
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
133
Xanthine Oxidase Inhibitor
3 molecules in class · 26 total generic manufacturers across the class
CY24 Part D spend$200.9M
Molecules3
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
134
5-alpha Reductase Inhibitor
4 molecules in class · 22 total generic manufacturers across the class
CY24 Part D spend$199.5M
Molecules4
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
135
HMG-CoA Reductase Inhibitor (Statin)
2 molecules in class · 15 total generic manufacturers across the class
CY24 Part D spend$199.2M
Molecules2
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
136
Hedgehog Pathway Inhibitor
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$196.4M
Molecules2
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
137
Acetylcholine Release Inhibitor
6 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$195.3M
Molecules6
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
138
Influenza A M2 Protein Inhibitor
1 molecule in class · 19 total generic manufacturers across the class
CY24 Part D spend$190.5M
Molecules1
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
139
Lipopeptide Antibacterial
2 molecules in class · 16 total generic manufacturers across the class
CY24 Part D spend$188.0M
Molecules2
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
140
Aluminum Complex
3 molecules in class · 13 total generic manufacturers across the class
CY24 Part D spend$186.8M
Molecules3
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
141
Tetracycline-class Antibacterial
2 molecules in class · 4 total generic manufacturers across the class
CY24 Part D spend$185.4M
Molecules2
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
142
Cephalosporin Antibacterial
13 molecules in class · 51 total generic manufacturers across the class
CY24 Part D spend$182.3M
Molecules13
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
143
Melatonin Receptor Agonist
2 molecules in class · 12 total generic manufacturers across the class
CY24 Part D spend$180.8M
Molecules2
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
144
Phenothiazine
9 molecules in class · 98 total generic manufacturers across the class
CY24 Part D spend$179.5M
Molecules9
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
148
Antihypoglycemic Agent
4 molecules in class · 4 total generic manufacturers across the class
CY24 Part D spend$172.2M
Molecules4
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
149
Sucrose-specific Enzyme
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$169.2M
Molecules1
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
150
Bile Acid Sequestrant
7 molecules in class · 26 total generic manufacturers across the class
CY24 Part D spend$168.2M
Molecules7
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
151
Carbonic Anhydrase Inhibitor
7 molecules in class · 39 total generic manufacturers across the class
CY24 Part D spend$167.6M
Molecules7
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
153
Aldosterone Antagonist
3 molecules in class · 20 total generic manufacturers across the class
CY24 Part D spend$164.5M
Molecules3
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
154
Opioid Analgesic
1 molecule in class · 12 total generic manufacturers across the class
CY24 Part D spend$163.2M
Molecules1
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
155
Anti-anginal
1 molecule in class · 20 total generic manufacturers across the class
CY24 Part D spend$162.9M
Molecules1
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
156
Bisphosphonate
3 molecules in class · 32 total generic manufacturers across the class
CY24 Part D spend$159.0M
Molecules3
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
157
Bile Acid
4 molecules in class · 14 total generic manufacturers across the class
CY24 Part D spend$156.9M
Molecules4
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
158
DMARD (Antimalarial)
1 molecule in class · 13 total generic manufacturers across the class
CY24 Part D spend$156.6M
Molecules1
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
159
Non-Benzodiazepine Hypnotic (Z-Drug)
2 molecules in class · 22 total generic manufacturers across the class
CY24 Part D spend$155.9M
Molecules2
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
160
Retinoid
19 molecules in class · 52 total generic manufacturers across the class
CY24 Part D spend$154.6M
Molecules19
Class share 0.1% of tracked Part D spend
Explorer
View class
Open →
161
Complement 5a Receptor Antagonist
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$149.9M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
162
Nuclear Export Inhibitor
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$147.9M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
163
Tetracycline-class Drug
3 molecules in class · 60 total generic manufacturers across the class
CY24 Part D spend$147.0M
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
164
Iron Chelator
4 molecules in class · 24 total generic manufacturers across the class
CY24 Part D spend$143.8M
Molecules4
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
165
Central alpha-2 Adrenergic Agonist
5 molecules in class · 65 total generic manufacturers across the class
CY24 Part D spend$138.5M
Molecules5
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
167
Arteriolar Vasodilator
2 molecules in class · 20 total generic manufacturers across the class
CY24 Part D spend$134.6M
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
169
Penem Antibacterial
3 molecules in class · 15 total generic manufacturers across the class
CY24 Part D spend$134.3M
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
170
gamma-Aminobutyric Acid-ergic Agonist
2 molecules in class · 21 total generic manufacturers across the class
CY24 Part D spend$134.2M
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
171
Aromatase Inhibitor
5 molecules in class · 20 total generic manufacturers across the class
CY24 Part D spend$132.6M
Molecules5
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
172
Potassium Channel Blocker
1 molecule in class · 5 total generic manufacturers across the class
CY24 Part D spend$126.7M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
173
Alkaloid
3 molecules in class · 17 total generic manufacturers across the class
CY24 Part D spend$124.2M
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
174
Interleukin-13 Antagonist
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$123.6M
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
175
Thiazide Diuretic
30 molecules in class · 103 total generic manufacturers across the class
CY24 Part D spend$122.0M
Molecules30
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
176
Calcium-sensing Receptor Agonist
1 molecule in class · 10 total generic manufacturers across the class
CY24 Part D spend$120.6M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
177
Low Molecular Weight Heparin
1 molecule in class · 9 total generic manufacturers across the class
CY24 Part D spend$118.4M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
179
Bradykinin B2 Receptor Antagonist
1 molecule in class · 8 total generic manufacturers across the class
CY24 Part D spend$116.7M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
180
Osmotic Laxative
13 molecules in class · 16 total generic manufacturers across the class
CY24 Part D spend$116.6M
Molecules13
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
181
Polyene Antifungal
6 molecules in class · 37 total generic manufacturers across the class
CY24 Part D spend$116.2M
Molecules6
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
182
Tyrosine Kinase 2 Inhibitor
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$115.4M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
184
Muscle Relaxant
6 molecules in class · 55 total generic manufacturers across the class
CY24 Part D spend$114.3M
Molecules6
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
185
Fluoroquinolone Antibacterial
6 molecules in class · 61 total generic manufacturers across the class
CY24 Part D spend$113.2M
Molecules6
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
188
Serotonin-4 Receptor Agonist
1 molecule in class · 16 total generic manufacturers across the class
CY24 Part D spend$103.9M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
189
Immunosuppressant
1 molecule in class · 24 total generic manufacturers across the class
CY24 Part D spend$101.8M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
190
Thiazide-like Diuretic
6 molecules in class · 35 total generic manufacturers across the class
CY24 Part D spend$99.9M
Molecules6
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
192
Folate Analog Metabolic Inhibitor
5 molecules in class · 28 total generic manufacturers across the class
CY24 Part D spend$93.3M
Molecules5
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
193
Protease Inhibitor
3 molecules in class · 14 total generic manufacturers across the class
CY24 Part D spend$90.0M
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
194
Chloride Channel Activator
1 molecule in class · 5 total generic manufacturers across the class
CY24 Part D spend$89.8M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
195
Opioid Antagonist
3 molecules in class · 25 total generic manufacturers across the class
CY24 Part D spend$89.7M
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
196
Nitroimidazole Antimicrobial
9 molecules in class · 29 total generic manufacturers across the class
CY24 Part D spend$88.0M
Molecules9
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
197
mu-Opioid Receptor Agonist
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$87.8M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
199
Cephalosporin (Antibiotic)
1 molecule in class · 8 total generic manufacturers across the class
CY24 Part D spend$81.6M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
200
Estrogen Agonist/Antagonist
4 molecules in class · 19 total generic manufacturers across the class
CY24 Part D spend$77.6M
Molecules4
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
201
Glucosylceramide Synthase Inhibitor
2 molecules in class · 5 total generic manufacturers across the class
CY24 Part D spend$77.4M
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
204
Glycopeptide Antibacterial
1 molecule in class · 21 total generic manufacturers across the class
CY24 Part D spend$75.0M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
205
Macrolide (Antibiotic)
1 molecule in class · 20 total generic manufacturers across the class
CY24 Part D spend$72.6M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
206
Antisense Oligonucleotide
4 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$71.6M
Molecules4
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
207
Neurokinin 3 Receptor Antagonist
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$70.1M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
208
Monoamine Oxidase Inhibitor
2 molecules in class · 14 total generic manufacturers across the class
CY24 Part D spend$69.9M
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
209
Antirheumatic Agent
2 molecules in class · 17 total generic manufacturers across the class
CY24 Part D spend$69.9M
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
210
Vitamin K Antagonist (Anticoagulant)
1 molecule in class · 6 total generic manufacturers across the class
CY24 Part D spend$68.3M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
213
Alkylating Drug
16 molecules in class · 77 total generic manufacturers across the class
CY24 Part D spend$64.9M
Molecules16
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
214
Lincosamide (Antibiotic)
1 molecule in class · 26 total generic manufacturers across the class
CY24 Part D spend$64.3M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
216
Cholinergic Receptor Agonist
2 molecules in class · 17 total generic manufacturers across the class
CY24 Part D spend$63.2M
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
218
Antimalarial
6 molecules in class · 17 total generic manufacturers across the class
CY24 Part D spend$61.4M
Molecules6
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
219
Progestin
10 molecules in class · 58 total generic manufacturers across the class
CY24 Part D spend$60.0M
Molecules10
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
221
Cortisol Synthesis Inhibitor
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$59.0M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
222
Sympathomimetic-like Agent
1 molecule in class · 6 total generic manufacturers across the class
CY24 Part D spend$58.4M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
225
Cardiac Glycoside
1 molecule in class · 10 total generic manufacturers across the class
CY24 Part D spend$55.2M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
227
Aminoglycoside Antibacterial
8 molecules in class · 41 total generic manufacturers across the class
CY24 Part D spend$53.3M
Molecules8
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
228
Interleukin-1 Receptor Antagonist
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$53.2M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
231
Norepinephrine Reuptake Inhibitor
1 molecule in class · 8 total generic manufacturers across the class
CY24 Part D spend$50.5M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
232
Quinolone Antimicrobial
9 molecules in class · 16 total generic manufacturers across the class
CY24 Part D spend$50.3M
Molecules9
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
233
Programmed Death Ligand-1 Blocker
3 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$49.7M
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
234
beta2-Adrenergic Agonist
5 molecules in class · 33 total generic manufacturers across the class
CY24 Part D spend$48.7M
Molecules5
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
235
Reducing and Complexing Thiol
1 molecule in class · 5 total generic manufacturers across the class
CY24 Part D spend$47.4M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
236
HER2/neu Receptor Antagonist
7 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$46.3M
Molecules7
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
237
Interferon alpha
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$46.2M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
238
Aminopenicillin (Antibiotic)
1 molecule in class · 8 total generic manufacturers across the class
CY24 Part D spend$45.7M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
239
5-Lipoxygenase Inhibitor
1 molecule in class · 4 total generic manufacturers across the class
CY24 Part D spend$45.5M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
240
Aromatic Amino Acid
3 molecules in class · 3 total generic manufacturers across the class
CY24 Part D spend$44.9M
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
241
Typical Antipsychotic
3 molecules in class · 25 total generic manufacturers across the class
CY24 Part D spend$44.8M
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
242
Thyroid Hormone
2 molecules in class · 18 total generic manufacturers across the class
CY24 Part D spend$43.1M
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
243
Aryl Hydrocarbon Receptor Agonist
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$43.0M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
244
Vitamin D3 Analog
2 molecules in class · 10 total generic manufacturers across the class
CY24 Part D spend$41.4M
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
246
Antiemetic
1 molecule in class · 9 total generic manufacturers across the class
CY24 Part D spend$38.7M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
247
Phenylalanine Metabolizing Enzyme
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$38.2M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
248
Ergotamine Derivative
1 molecule in class · 9 total generic manufacturers across the class
CY24 Part D spend$38.0M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
250
Vitamin D Analog
3 molecules in class · 8 total generic manufacturers across the class
CY24 Part D spend$35.6M
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
251
Proteasome Inhibitor
2 molecules in class · 18 total generic manufacturers across the class
CY24 Part D spend$35.5M
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
252
Oxaborole Antifungal
2 molecules in class · 5 total generic manufacturers across the class
CY24 Part D spend$34.1M
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
254
Phenylalanine Hydroxylase Activator
1 molecule in class · 8 total generic manufacturers across the class
CY24 Part D spend$32.7M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
256
CCR5 Co-receptor Antagonist
1 molecule in class · 4 total generic manufacturers across the class
CY24 Part D spend$32.6M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
257
Glinide
2 molecules in class · 10 total generic manufacturers across the class
CY24 Part D spend$29.5M
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
258
CD38-directed Cytolytic Antibody
3 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$29.3M
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
259
Leptin Analog
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$28.8M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
260
mTOR Inhibitor Immunosuppressant
1 molecule in class · 10 total generic manufacturers across the class
CY24 Part D spend$27.8M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
261
Thrombopoietin Receptor Agonist
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$27.5M
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
262
Lipoglycopeptide Antibacterial
2 molecules in class · 4 total generic manufacturers across the class
CY24 Part D spend$27.2M
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
263
Oxazolidinone Antibacterial
1 molecule in class · 18 total generic manufacturers across the class
CY24 Part D spend$26.9M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
264
Phosphodiesterase 3 Inhibitor
3 molecules in class · 15 total generic manufacturers across the class
CY24 Part D spend$26.4M
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
266
Somatostatin Analog
2 molecules in class · 9 total generic manufacturers across the class
CY24 Part D spend$24.4M
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
267
DPP-4 Inhibitor (Antidiabetic)
1 molecule in class · 3 total generic manufacturers across the class
CY24 Part D spend$24.2M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
268
Vasopressin Analog
1 molecule in class · 13 total generic manufacturers across the class
CY24 Part D spend$24.1M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
269
Ergot Derivative
3 molecules in class · 17 total generic manufacturers across the class
CY24 Part D spend$23.1M
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
271
Antimetabolite
2 molecules in class · 6 total generic manufacturers across the class
CY24 Part D spend$21.1M
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
272
Penicillin-class Antibacterial
7 molecules in class · 27 total generic manufacturers across the class
CY24 Part D spend$20.6M
Molecules7
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
273
Provitamin D2 Compound
5 molecules in class · 4 total generic manufacturers across the class
CY24 Part D spend$20.2M
Molecules5
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
274
Dopamine-2 Receptor Antagonist
3 molecules in class · 12 total generic manufacturers across the class
CY24 Part D spend$20.1M
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
275
Antiparasitic
1 molecule in class · 9 total generic manufacturers across the class
CY24 Part D spend$19.9M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
276
Anthelmintic
4 molecules in class · 8 total generic manufacturers across the class
CY24 Part D spend$19.7M
Molecules4
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
277
Thyroid Hormone Synthesis Inhibitor
2 molecules in class · 11 total generic manufacturers across the class
CY24 Part D spend$19.1M
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
278
Blood Viscosity Reducer
1 molecule in class · 3 total generic manufacturers across the class
CY24 Part D spend$19.0M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
279
Benzothiazole
1 molecule in class · 4 total generic manufacturers across the class
CY24 Part D spend$19.0M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
281
CTLA-4-directed Blocking Antibody
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$18.5M
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
283
Nicotinic Acid
1 molecule in class · 10 total generic manufacturers across the class
CY24 Part D spend$18.1M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
284
Sulfonamide Antibacterial
3 molecules in class · 1 total generic manufacturers across the class
CY24 Part D spend$16.6M
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
285
Cholinergic Muscarinic Agonist
2 molecules in class · 4 total generic manufacturers across the class
CY24 Part D spend$15.9M
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
287
Allylamine Antifungal
1 molecule in class · 7 total generic manufacturers across the class
CY24 Part D spend$15.3M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
288
Mast Cell Stabilizer
1 molecule in class · 8 total generic manufacturers across the class
CY24 Part D spend$15.2M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
289
Pyrethroid
2 molecules in class · 3 total generic manufacturers across the class
CY24 Part D spend$14.0M
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
290
Echinocandin Antifungal
4 molecules in class · 14 total generic manufacturers across the class
CY24 Part D spend$13.5M
Molecules4
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
291
Interleukin-17 Receptor A Antagonist
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$13.1M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
292
Histone Deacetylase Inhibitor
3 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$13.1M
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
294
Cholinergic Nicotinic Agonist
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$12.6M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
295
Interleukin-36 Receptor Antagonist
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$12.1M
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
296
Antidiarrheal
2 molecules in class · 8 total generic manufacturers across the class
CY24 Part D spend$11.8M
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
298
Sulfone
4 molecules in class · 16 total generic manufacturers across the class
CY24 Part D spend$11.5M
Molecules4
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
299
Nucleoside Analog Antifungal
1 molecule in class · 5 total generic manufacturers across the class
CY24 Part D spend$11.4M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
300
Rifamycin Antimycobacterial
3 molecules in class · 1 total generic manufacturers across the class
CY24 Part D spend$11.2M
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
301
Pyruvate Kinase Activator
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$10.7M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
302
alpha-Glucosidase Inhibitor
2 molecules in class · 7 total generic manufacturers across the class
CY24 Part D spend$10.4M
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
304
Vitamin C
53 molecules in class · 11 total generic manufacturers across the class
CY24 Part D spend$10.2M
Molecules53
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
305
Cannabinoid
2 molecules in class · 1 total generic manufacturers across the class
CY24 Part D spend$10.2M
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
306
Amino Acid
14 molecules in class · 1 total generic manufacturers across the class
CY24 Part D spend$10.0M
Molecules14
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
307
Cytochrome P450 3A Inhibitor
8 molecules in class · 10 total generic manufacturers across the class
CY24 Part D spend$9.8M
Molecules8
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
308
Nitrofuran Antibacterial
9 molecules in class · 21 total generic manufacturers across the class
CY24 Part D spend$9.8M
Molecules9
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
309
Potassium-sparing Diuretic
3 molecules in class · 4 total generic manufacturers across the class
CY24 Part D spend$9.6M
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
310
Copper Chelator
1 molecule in class · 9 total generic manufacturers across the class
CY24 Part D spend$8.7M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
311
Microtubule Inhibitor
6 molecules in class · 32 total generic manufacturers across the class
CY24 Part D spend$8.3M
Molecules6
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
314
Macrolide Antimicrobial
1 molecule in class · 10 total generic manufacturers across the class
CY24 Part D spend$7.9M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
315
Tetracycline-class Antimicrobial
1 molecule in class · 6 total generic manufacturers across the class
CY24 Part D spend$7.9M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
316
Antifibrinolytic Agent
2 molecules in class · 38 total generic manufacturers across the class
CY24 Part D spend$7.8M
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
320
Folate Analog
2 molecules in class · 16 total generic manufacturers across the class
CY24 Part D spend$7.4M
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
321
Platelet-reducing Agent
1 molecule in class · 4 total generic manufacturers across the class
CY24 Part D spend$7.3M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
322
Catecholamine Synthesis Inhibitor
1 molecule in class · 3 total generic manufacturers across the class
CY24 Part D spend$6.6M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
323
CD30-directed Immunoconjugate
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$6.5M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
324
Carnitine Analog
2 molecules in class · 6 total generic manufacturers across the class
CY24 Part D spend$6.2M
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
325
Antiprotozoal
2 molecules in class · 7 total generic manufacturers across the class
CY24 Part D spend$6.2M
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
327
Sodium Channel Blocker
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$5.7M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
328
Histamine-1 Receptor Inhibitor
1 molecule in class · 3 total generic manufacturers across the class
CY24 Part D spend$5.4M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
329
Vitamin D2 Analog
2 molecules in class · 19 total generic manufacturers across the class
CY24 Part D spend$5.4M
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
330
Macrolide
4 molecules in class · 20 total generic manufacturers across the class
CY24 Part D spend$5.3M
Molecules4
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
331
Prostaglandin E1 Analog
3 molecules in class · 7 total generic manufacturers across the class
CY24 Part D spend$5.3M
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
332
Potassium Binder
2 molecules in class · 9 total generic manufacturers across the class
CY24 Part D spend$4.5M
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
333
Medium-chain Triglyceride
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$4.4M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
335
Monobactam Antibacterial
1 molecule in class · 2 total generic manufacturers across the class
CY24 Part D spend$3.8M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
337
Lipid-based Polyene Antifungal
2 molecules in class · 5 total generic manufacturers across the class
CY24 Part D spend$3.7M
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
338
Opioid Agonist/Antagonist
2 molecules in class · 6 total generic manufacturers across the class
CY24 Part D spend$3.5M
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
340
Aldehyde Dehydrogenase Inhibitor
1 molecule in class · 3 total generic manufacturers across the class
CY24 Part D spend$3.5M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
341
Non-narcotic Antitussive
1 molecule in class · 8 total generic manufacturers across the class
CY24 Part D spend$3.4M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
343
Methylating Agent
3 molecules in class · 2 total generic manufacturers across the class
CY24 Part D spend$3.2M
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
346
Antidote
3 molecules in class · 18 total generic manufacturers across the class
CY24 Part D spend$3.0M
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
347
Nucleoside Analog Antiviral
3 molecules in class · 7 total generic manufacturers across the class
CY24 Part D spend$2.8M
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
348
Antileishmanial
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$2.8M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
349
Adrenal Steroid Synthesis Inhibitor
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$2.1M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
350
Platinum-based Drug
3 molecules in class · 31 total generic manufacturers across the class
CY24 Part D spend$1.8M
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
351
Platelet Aggregation Inhibitor
2 molecules in class · 16 total generic manufacturers across the class
CY24 Part D spend$1.8M
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
353
Antimycobacterial
4 molecules in class · 8 total generic manufacturers across the class
CY24 Part D spend$1.8M
Molecules4
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
354
Interferon gamma Blocker
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$1.3M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
355
Polyene Antimicrobial
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$1.3M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
356
Complement Factor D Inhibitor
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$1.3M
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
358
Urease Inhibitor
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$975426
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
359
Pediculicide
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$930240
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
360
Amyloid Beta-directed Antibody
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$856927
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
361
Photoactivated Radical Generator
1 molecule in class · 1 total generic manufacturers across the class
CY24 Part D spend$785078
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
362
Topoisomerase Inhibitor
3 molecules in class · 27 total generic manufacturers across the class
CY24 Part D spend$780820
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
364
Lincosamide Antibacterial
4 molecules in class · 7 total generic manufacturers across the class
CY24 Part D spend$730703
Molecules4
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
365
Intestinal Lipase Inhibitor
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$595414
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
366
Hematopoietic Stem Cell Mobilizer
1 molecule in class · 8 total generic manufacturers across the class
CY24 Part D spend$534430
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
368
Thyroid Stimulating Hormone
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$467014
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
369
Analgesic/Antipyretic
1 molecule in class · 10 total generic manufacturers across the class
CY24 Part D spend$179365
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
370
Lead Chelator
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$165312
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
371
Osmotic Diuretic
2 molecules in class · 1 total generic manufacturers across the class
CY24 Part D spend$125842
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
372
Benzodiazepine Antagonist
1 molecule in class · 7 total generic manufacturers across the class
CY24 Part D spend$76946
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
375
alpha-1 Adrenergic Agonist
2 molecules in class · 16 total generic manufacturers across the class
CY24 Part D spend$56521
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
376
Local Anesthetic
1 molecule in class · 6 total generic manufacturers across the class
CY24 Part D spend$48308
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
377
Polymyxin-class Antibacterial
2 molecules in class · 8 total generic manufacturers across the class
CY24 Part D spend$29910
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
378
Neuraminidase Inhibitor
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend$24175
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
380
Sympathomimetic Amine Anorectic
1 molecule in class · 12 total generic manufacturers across the class
CY24 Part D spend$17447
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
381
Progesterone
1 molecule in class · 8 total generic manufacturers across the class
CY24 Part D spend$11832
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
382
Cytoprotective Agent
2 molecules in class · 8 total generic manufacturers across the class
CY24 Part D spend$1356
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
383
Antiseptic
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend$1323
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
384
Radioactive Diagnostic Agent
27 molecules in class · 3 total generic manufacturers across the class
CY24 Part D spend
Molecules27
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
385
Radiographic Contrast Agent
17 molecules in class · 3 total generic manufacturers across the class
CY24 Part D spend
Molecules17
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
386
Vitamin D
12 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules12
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
387
Calculi Dissolution Agent
11 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules11
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
388
General Anesthetic
10 molecules in class · 33 total generic manufacturers across the class
CY24 Part D spend
Molecules10
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
390
Barbiturate
8 molecules in class · 25 total generic manufacturers across the class
CY24 Part D spend
Molecules8
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
391
Endoglycosidase
7 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules7
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
392
Vitamin B12
6 molecules in class · 16 total generic manufacturers across the class
CY24 Part D spend
Molecules6
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
393
Lipid Emulsion
5 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules5
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
394
Parenteral Iron Replacement
5 molecules in class · 5 total generic manufacturers across the class
CY24 Part D spend
Molecules5
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
396
Tubulin Inhibiting Agent
5 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules5
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
397
Human Immunoglobulin G
4 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules4
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
399
Standardized Chemical Allergen
4 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules4
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
400
Vasodilator
4 molecules in class · 13 total generic manufacturers across the class
CY24 Part D spend
Molecules4
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
401
Adenosine Receptor Agonist
3 molecules in class · 9 total generic manufacturers across the class
CY24 Part D spend
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
402
Adrenocorticotropic Hormone
3 molecules in class · 1 total generic manufacturers across the class
CY24 Part D spend
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
403
Anti-coagulant
3 molecules in class · 13 total generic manufacturers across the class
CY24 Part D spend
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
404
Asparagine-specific Enzyme
3 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
406
Neonatal Fc Receptor Blocker
3 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
407
Plasma Volume Expander
3 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
409
Sulfonamide Antimicrobial
3 molecules in class · 12 total generic manufacturers across the class
CY24 Part D spend
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
410
Surfactant
3 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
411
beta Lactamase Inhibitor
3 molecules in class · 8 total generic manufacturers across the class
CY24 Part D spend
Molecules3
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
413
Antimetabolite Immunosuppressant
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
416
Gonadotropin
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
417
Hepatitis C Virus NS5A Inhibitor
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
418
Inhalation Diagnostic Agent
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
419
Melanin Synthesis Inhibitor
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
420
Paramagnetic Contrast Agent
2 molecules in class · 1 total generic manufacturers across the class
CY24 Part D spend
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
421
Skin Test Antigen
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
422
Topical Corticosteroid
2 molecules in class · 33 total generic manufacturers across the class
CY24 Part D spend
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
423
Vitamin K
2 molecules in class · 15 total generic manufacturers across the class
CY24 Part D spend
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
424
l-Thyroxine
2 molecules in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules2
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
425
APOC-III-directed RNA Interaction
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
426
Actinomycin
1 molecule in class · 4 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
427
Angiopoietin-like 3 Inhibitor
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
428
Antihistamine
1 molecule in class · 4 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
430
Bispecific HER2-directed Antibody
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
432
CD123 Interaction
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
433
CD19-directed Cytolytic Antibody
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
434
CD22-directed Immunoconjugate
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
435
CD25-directed Cytotoxin
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
436
CD3-directed Antibody
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
437
CD33-directed Immunoconjugate
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
438
CD4-directed Blocking Antibody
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
439
CD52-directed Cytolytic Antibody
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
440
CNS Stimulant (Amphetamine)
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
441
CXC Chemokine Receptor 4 Antagonist
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
442
Calcitonin
1 molecule in class · 9 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
443
Calcium
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
444
Carboxypeptidase
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
445
Catecholamine
1 molecule in class · 17 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
446
Cholecystokinin Analog
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
449
Complement C5 Inhibitor
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
451
Cytolytic Agent
1 molecule in class · 1 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
452
Decorporation Agent
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
453
Depolarizing Neuromuscular Blocker
1 molecule in class · 18 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
454
Diagnostic Dye
1 molecule in class · 1 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
455
Disclosing Agent
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
456
Ectoparasiticide
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
457
Erythroid Maturation Agent
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
458
Erythropoiesis-stimulating Agent
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
459
Expectorant
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
460
Farnesyltransferase Inhibitor
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
461
Gadolinium-based Contrast Agent
1 molecule in class · 2 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
462
Gamma Secretase Inhibitor
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
464
Helicobacter pylori Diagnostic
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
466
Human Blood Coagulation Factor
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
467
Human Immunoglobulin
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
470
Hyperpolarized Contrast Agent
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
471
Immunoglobulin G
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
472
Inhaled Corticosteroid
1 molecule in class · 9 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
473
Insulin
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
475
Interferon alfa-2b
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
476
Interferon gamma
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
478
Interleukin-6 Antagonist
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
480
Lymphocyte Growth Factor
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
481
Lysosomal beta Glucuronidase
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
482
Melanocortin 4 Receptor Agonist
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
483
Menin Inhibitor
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
484
Methylxanthine
1 molecule in class · 18 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
486
Nitrogen Binding Agent
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
488
Oxidation-Reduction Agent
1 molecule in class · 7 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
489
Oxytocic
1 molecule in class · 2 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
490
Parathyroid Hormone
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
491
Partial Opioid Agonist/Antagonist
1 molecule in class · 3 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
493
Photoenhancer
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
494
Prostacycline
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
495
Renal Dehydropeptidase Inhibitor
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
496
Sclerosing Agent
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
497
Selectin Blocker
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
498
Semifluorinated Alkane
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
502
Unfractionated Heparin
1 molecule in class · 9 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
503
Vasoconstrictor
1 molecule in class · 1 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
504
Vasopressin Receptor Agonist
1 molecule in class · 0 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
506
alpha-Hydroxy Acid
1 molecule in class · 4 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →
507
beta-Adrenergic Agonist
1 molecule in class · 11 total generic manufacturers across the class
CY24 Part D spend
Molecules1
Class share 0.0% of tracked Part D spend
Explorer
View class
Open →